Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

Lena Specht, MD, DSc, PhD

Dept. of Oncology, Rigshospitalet, University of Copenhagen
Charlottenlund, Capital Region, Denmark

Professor Lena Specht is Professor of Oncology at the University of Copenhagen, Denmark. She completed her training in Clinical Oncology at the University Hospital in Copenhagen. She held a research fellowship for three years at the Danish Cancer Society, and she obtained her DMSc degree with work on prognostic factors in Hodgkin lymphoma.


Professor Specht is Chief Oncologist at the Department of Oncology at Rigshospitalet, University of Copenhagen. Her main areas of research and clinical interest are lymphomas and head & neck cancer. She is author of over 300 research articles and educational papers, including ILROG guidelines on lymphoma radiation therapy and ESMO guidelines on peripheral T-cell lymphomas and cutaneous lymphomas. She has authored three textbooks and numerous book chapters. She has served on numerous national and international research evaluation committees, including Cancer Research UK, the Swiss Cancer League, and the Swedish Research Council. She leads a Multidisciplinary Radiotherapy Research Group, comprising physicians, physicists, and civil engineers, and she has supervised 18 PhD projects and numerous post doc, postgraduate, and pregraduate projects. She is Editor of the Cochrane Haematological Malignancies Group and member of the Advisory Board for Acta Oncologica. She is Chairman of the Radiotherapy Committee of the Danish Lymphoma Group, and she is Vice President of the International Lymphoma Radiation Oncology Group (ILROG). She has given 180 invited international research and teaching lectures worldwide, and she is Course Director for the ESTRO-ILROG School Course on Haematological Malignancies. She was awarded an ESTRO Lifetime Achievement Award in 2022.

Disclosures:

  • Employment: Institute of Clinical Medicine, University of Copenhagen, Denmark:Professor of Oncology:Employee;Rigshospitalet, Copenhagen University Hospital:Chief Oncologist:Employee
  • Compensation: Takeda: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 2022 ;Kyowa Kirin Co. Ltd: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Research Grants, Research Funding, Research Salary Support, Honoraria-End Date: ongoing
  • Ownership: none
  • Leadership: Danish Lymphoma Group:Board Member;Danish Lymphoma Radiation Oncology Group:Chairman;International Lymphoma Radiation Oncology Group:Vice-Chairman

Presentation(s):